In patients with IDH2-mutated AML also co-mutated with either NPM1 and/or FLT3-ITD, the persistence of only IDH2m pre-transplant was not associated with increased relapse post-transplant. The gene discussed is NPM1; the disease is acute myeloid leukemia.